Submission for OMB Review; Comment Request; The National Diabetes Education Program Survey of the Public, 38072-38073 [2012-15594]
Download as PDF
<![CDATA[
rmajette on DSK2TPTVN1PROD with NOTICES
38072
Federal Register / Vol. 77, No. 123 / Tuesday, June 26, 2012 / Notices
Network policies; (2) administers the
C.W. Bill Young Cell Transplantation
Program to increase the number of
unrelated blood stem cell transplants
and improve the outcomes of blood
stem cell transplants; (3) administers the
National Cord Blood Inventory to
increase the number of high quality cord
blood units available for
transplantation; (4) develops and
maintains a national program of grants
and contracts to organ procurement
organizations and other entities to
increase the number of organs made
available for transplantation; (5)
manages the national program for
compliance with the Hill-Burton
uncompensated care requirement and
other assurances; (6) directs and
administers a congressionally-directed
grant program for the construction/
renovation/equipping of health care and
other facilities; (7) directs and
administers the National Vaccine Injury
Compensation Program; (8) manages
and promotes the 340B Drug Pricing
Program; (9) directs and administers the
Poison Center Support, Enhancement,
and Awareness Act; and (10)
implements and administers the
Countermeasures Injury Compensation
Program under PREP Act authorities.
The Countermeasures Injury
Compensation Program administers the
Federal compensation program
established by the Public Readiness and
Emergency Preparedness Act (‘‘PREP
Act’’) enacted as Division C of the
Defense Appropriations Act for fiscal
year 2006, Public Law 109–148, which
added new authorities under the Public
Health Service (PHS) Act to alleviate
concerns about liability related to the
manufacture, testing, development,
distribution, administration, and use of
countermeasures against chemical,
biological, radiological and nuclear
agents of terrorism, epidemics, and
pandemics. The program discharges all
PREP Act authorities regarding
compensation including: (1) Developing
and disseminating requests for benefits
information to inform individuals that
the Countermeasures Injury
Compensation Program exists so that
people requesting benefits do not miss
the 1-year filing deadline; (2) accepting
letters of intent to file requests for
benefits so that individuals preserve
their rights to file by the 1-year
deadline; (3) evaluating requests for
benefits for compensation filed under
the Countermeasures Injury
Compensation Program through medical
review and assessment of
compensability for all complete claims;
(4) processing requests for benefits made
under the Countermeasures Injury
VerDate Mar<15>2010
15:33 Jun 25, 2012
Jkt 226001
Compensation Program; (5)
promulgating regulations to create and
revise the Countermeasures Injury
Compensation Program Vaccine Injury
Tables; (6) developing and maintaining
all automated information systems
necessary for Program implementation;
and (7) collecting, analyzing and
disseminating Program information.
manages the national Hill-Burton
Hotline to ensure that consumers
receive timely and accurate information
on the program; and (8) provides
architectural and engineering services to
other Agencies such as the
Administration for Children and
Families and the Food and Drug
Administration.
Division of Poison Control and
Healthcare Facilities (RR9)
The Division of Poison Control and
Healthcare Facilities administers the
Poison Control Program, substantiates
health facilities’ compliance with the
Hill-Burton uncompensated services
assurance, and administers construction
grants under section 1610(b) of the
Public Health Service Act, under the
Health Care and Other Facilities
program, and under the Patient
Protection and Affordable Care Act,
Public Law 111–148. Specifically, the
Division: (1) Administers the activities
authorized by the Poison Center
Support, Enhancement and Awareness
Act of 2008, which includes: (a)
Maintaining the national toll-free Poison
Help hotline (800–222–1222), (b)
implementing and expanding a national
media campaign to educate the public
and health care providers about
poisoning prevention, and (c) awarding
grants to poison control centers; (2)
administers the process for awarding
new construction and equipment grants,
under section 1610(b), the Health Care
and Other Facilities, and the Patient
Protection and Affordable Care Act
programs, including ensuring the
delivery of comprehensive architectural
and engineering services and ensuring
compliance with historic preservation
and other laws and regulations related
to construction projects, maintaining a
computerized database of key project
information, and providing technical
assistance in application preparation to
potential grantees under Division grant
programs; (3) monitors grant projects
during construction to assure
compliance with the terms of the award,
including reviewing requests for
changes in scope to grant projects and
obtaining information needed to close
out completed grant projects; (4)
establishes, develops, monitors, and
enforces the implementation of HillBurton regulations, policies, procedures,
and guidelines for use by staff and
health care facilities; (5) maintains a
system for receipt, analysis and
disposition of audit appeals by HillBurton obligated facilities and for
receiving and responding to patient
complaints; (6) manages the recovery or
waiver of recovery of Federal grant
funds process for Titles VI and XVI; (7)
Section RR–30, Delegations of Authority
All delegations of authority and redelegations of authority made to HRSA
officials that were in effect immediately
prior to this reorganization, and that are
consistent with this reorganization,
shall continue in effect pending further
re-delegation.
This reorganization is effective upon
date of signature.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Dated: June 14, 2012.
Mary K. Wakefield,
Administrator.
[FR Doc. 2012–15474 Filed 6–25–12; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Comment Request; The National
Diabetes Education Program Survey of
the Public
Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institute of Diabetes and Digestive and
Kidney Diseases (NIDDK), the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request to review and approve
the reinstatement without change for the
information collection listed below. The
proposed reinstatement without change
for the information collection was
previously published in the Federal
Register on January 25, 2012, pages
3783–3784 and allowed 60 days for
public comment. The National Institutes
of Health received no comments. The
purpose of this notice is to allow an
additional 30 days for public comment.
The National Institutes of Health may
not conduct or sponsor, and the
respondent is not required to respond
to, the collection of information that has
been extended, revised, or implemented
unless it displays a currently valid OMB
control number.
Proposed Collection: Title: The
National Diabetes Education Program
Survey of the Public. Type of
Information Collection Request:
Reinstatement without change for the
approved information collection
SUMMARY:
E:\FR\FM\26JNN1.SGM
26JNN1
38073
Federal Register / Vol. 77, No. 123 / Tuesday, June 26, 2012 / Notices
(#0925–0552). Need and Use of
Information Collection: The National
Diabetes Education Program (NDEP) is a
partnership of the National Institutes of
Health (NIH) and the Centers for Disease
Control and Prevention (CDC) and more
than 200 public and private
organizations.
The longterm goal of the NDEP is to
reduce the burden of diabetes and prediabetes in the United States, and its
territories, by facilitating the adoption of
proven strategies to prevent or delay the
onset of diabetes and its complications.
The NDEP objectives are to: (1) Increase
awareness and knowledge of the
seriousness of diabetes, its risk factors,
and effective strategies for preventing
type 2 diabetes and complications
associated with diabetes; (2) increase
the number of people who live well
with diabetes and effectively manage
their disease to prevent or delay
complications and improve quality of
life; (3) decrease the number of
Americans with undiagnosed diabetes;
(4) Among people at risk for type 2
diabetes, increase the number who make
and sustain effective lifestyle changes to
prevent diabetes; (5) facilitate efforts to
improve diabetes-related health care
and education, as well as systems for
delivering care; (6) reduce health
disparities in populations
disproportionately burdened by
diabetes; and (7) facilitate the
incorporation of evidence-based
research findings into health care
practices.
Multiple strategies have been devised
to address the NDEP objectives. These
have been described in the NDEP
Strategic Plan and include: (1)
Promoting and implementing culturally
and linguistically-appropriate diabetes
awareness and education campaigns for
a wide variety of audiences; (2)
identifying, disseminating, and
supporting the adoption of evidencebased, culturally and linguisticallyappropriate tools and resources that
support behavior change, improved
quality of life, and better diabetes
outcomes; (3) expanding NDEP reach
and visibility through collaborations
with public, private, and nontraditional
partners, and use of national, state, and
local media, traditional and social
media, and other relevant channels; and
(4) conducting and supporting the
evaluation of NDEP resources,
promotions, and other activities to
improve future NDEP initiatives.
The NDEP evaluation will document
the extent to which the NDEP program
has been implemented, and how
successful it has been in meeting
program objectives. The evaluation
relies heavily on data gathered from
existing national surveys such as
National Health and Nutrition
Examination Survey (NHANES), the
National Health Interview Survey
(NHIS), and the Behavioral Risk Factor
Surveillance System (BRFSS), among
others for this information. This generic
clearance request is for the collection of
additional primary data from NDEP
target audiences on key impact
measures that are necessary to
effectively evaluate the program.
Approval is requested for a survey of
audiences targeted by the National
Diabetes Education Program including
people at risk for diabetes and people
with diabetes and their families and the
public.
Frequency of Response: One occasion.
Affected Public: Individuals or
households. Type of Respondents:
Adults. The annual reporting burden is
as follows: Estimated Number of
Respondents: 3759; Estimated Number
of Responses per Respondent: 1;
Average Burden Hours per Response:
.153; and Estimated Total Annual
Burden Hours Requested: 575. There are
no Capital Costs, Operating or
Maintenance Costs to report.
ESTIMATES OF HOUR BURDEN
Number of
respondents
Type of respondents
Frequency of
response
Average time
per response
Total hour
burden
1,659
2,100
1
1
.03
.25
50
525
Totals ........................................................................................................
rmajette on DSK2TPTVN1PROD with NOTICES
Screening interview with ineligible persons .....................................................
Eligible respondents ........................................................................................
3,759
........................
........................
575
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Evaluate the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
VerDate Mar<15>2010
15:33 Jun 25, 2012
Jkt 226001
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the Office of
Management and Budget, Office of
Regulatory Affairs,
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974, Attention, Desk
Officer for NIH. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact Joanne
Gallivan, M.S., R.D., Director, National
Diabetes Education Program, NIDDK,
NIH, Building 31, Room 9A06, 31
Center Drive, Bethesda, MD 20892, or
call non-toll-free number (301) 494–
6110 or Email your request, including
your address to:
Joanne_Gallivan@nih.gov.
Comments Due Date: Comments
regarding this information collection are
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
best assured of having their full effect if
received within 30 days of the date of
this publication.
Dated: April 20, 2012.
Camille Hoover,
Executive Officer, NIDDK.
[FR Doc. 2012–15594 Filed 6–25–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Laboratory Animal Welfare:
Clarification of Position Statements on
Implementation of the Eighth Edition of
the Guide for the Care and Use of
Laboratory Animals
AGENCY:
National Institutes of Health,
HHS.
E:\FR\FM\26JNN1.SGM
26JNN1
]]>Agencies
[Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)]
[Notices]
[Pages 38072-38073]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-15594]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; Comment Request; The National Diabetes
Education Program Survey of the Public
SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National Institute of Diabetes and Digestive
and Kidney Diseases (NIDDK), the National Institutes of Health (NIH)
has submitted to the Office of Management and Budget (OMB) a request to
review and approve the reinstatement without change for the information
collection listed below. The proposed reinstatement without change for
the information collection was previously published in the Federal
Register on January 25, 2012, pages 3783-3784 and allowed 60 days for
public comment. The National Institutes of Health received no comments.
The purpose of this notice is to allow an additional 30 days for public
comment. The National Institutes of Health may not conduct or sponsor,
and the respondent is not required to respond to, the collection of
information that has been extended, revised, or implemented unless it
displays a currently valid OMB control number.
Proposed Collection: Title: The National Diabetes Education Program
Survey of the Public. Type of Information Collection Request:
Reinstatement without change for the approved information collection
[[Page 38073]]
(0925-0552). Need and Use of Information Collection: The
National Diabetes Education Program (NDEP) is a partnership of the
National Institutes of Health (NIH) and the Centers for Disease Control
and Prevention (CDC) and more than 200 public and private
organizations.
The longterm goal of the NDEP is to reduce the burden of diabetes
and pre-diabetes in the United States, and its territories, by
facilitating the adoption of proven strategies to prevent or delay the
onset of diabetes and its complications. The NDEP objectives are to:
(1) Increase awareness and knowledge of the seriousness of diabetes,
its risk factors, and effective strategies for preventing type 2
diabetes and complications associated with diabetes; (2) increase the
number of people who live well with diabetes and effectively manage
their disease to prevent or delay complications and improve quality of
life; (3) decrease the number of Americans with undiagnosed diabetes;
(4) Among people at risk for type 2 diabetes, increase the number who
make and sustain effective lifestyle changes to prevent diabetes; (5)
facilitate efforts to improve diabetes-related health care and
education, as well as systems for delivering care; (6) reduce health
disparities in populations disproportionately burdened by diabetes; and
(7) facilitate the incorporation of evidence-based research findings
into health care practices.
Multiple strategies have been devised to address the NDEP
objectives. These have been described in the NDEP Strategic Plan and
include: (1) Promoting and implementing culturally and linguistically-
appropriate diabetes awareness and education campaigns for a wide
variety of audiences; (2) identifying, disseminating, and supporting
the adoption of evidence-based, culturally and linguistically-
appropriate tools and resources that support behavior change, improved
quality of life, and better diabetes outcomes; (3) expanding NDEP reach
and visibility through collaborations with public, private, and
nontraditional partners, and use of national, state, and local media,
traditional and social media, and other relevant channels; and (4)
conducting and supporting the evaluation of NDEP resources, promotions,
and other activities to improve future NDEP initiatives.
The NDEP evaluation will document the extent to which the NDEP
program has been implemented, and how successful it has been in meeting
program objectives. The evaluation relies heavily on data gathered from
existing national surveys such as National Health and Nutrition
Examination Survey (NHANES), the National Health Interview Survey
(NHIS), and the Behavioral Risk Factor Surveillance System (BRFSS),
among others for this information. This generic clearance request is
for the collection of additional primary data from NDEP target
audiences on key impact measures that are necessary to effectively
evaluate the program. Approval is requested for a survey of audiences
targeted by the National Diabetes Education Program including people at
risk for diabetes and people with diabetes and their families and the
public.
Frequency of Response: One occasion. Affected Public: Individuals
or households. Type of Respondents: Adults. The annual reporting burden
is as follows: Estimated Number of Respondents: 3759; Estimated Number
of Responses per Respondent: 1; Average Burden Hours per Response:
.153; and Estimated Total Annual Burden Hours Requested: 575. There are
no Capital Costs, Operating or Maintenance Costs to report.
Estimates of Hour Burden
----------------------------------------------------------------------------------------------------------------
Number of Frequency of Average time Total hour
Type of respondents respondents response per response burden
----------------------------------------------------------------------------------------------------------------
Screening interview with ineligible persons..... 1,659 1 .03 50
Eligible respondents............................ 2,100 1 .25 525
---------------------------------------------------------------
Totals...................................... 3,759 .............. .............. 575
----------------------------------------------------------------------------------------------------------------
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Evaluate whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) Evaluate the
quality, utility, and clarity of the information to be collected; and
(4) Minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention, Desk Officer for NIH. To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact Joanne Gallivan, M.S., R.D., Director, National
Diabetes Education Program, NIDDK, NIH, Building 31, Room 9A06, 31
Center Drive, Bethesda, MD 20892, or call non-toll-free number (301)
494-6110 or Email your request, including your address to: Joanne_Gallivan@nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
Dated: April 20, 2012.
Camille Hoover,
Executive Officer, NIDDK.
[FR Doc. 2012-15594 Filed 6-25-12; 8:45 am]
BILLING CODE 4140-01-P
